5:22 PM
 | 
Oct 29, 2012
 |  BC Extra  |  Top Story

ViiV to acquire assets from Shionogi JV

ViiV Healthcare Ltd. will acquire exclusive, worldwide rights to develop and commercialize a portfolio of HIV integrase inhibitors from Shionogi-ViiV Healthcare LLC, a JV between ViiV and Shionogi & Co. Ltd. (Tokyo:4507; Osaka:4507). The portfolio includes dolutegravir ( S/GSK1349572), for...

Read the full 196 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >